Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The following presentations were recorded for the virtual Multiple Myeloma Patient Education Symposium, hosted by Dana-Farber Cancer Institute. A live Q&A session will be held via Zoom on February 18, 2023, at 11:00 ET (Passcode: 210383). Please submit questions by February 15 to email@example.com.
Ken Anderson, MD, on Therapeutic Advances in Multiple MyelomaDr. Ken Anderson gives a comprehensive update on research and treatment of multiple myeloma, including new advances presented at the American Society of Hematology Annual Meeting in 2022.
The complete playlist for the 2023 Multiple Myeloma Patient Education Symposium
Update in Myeloma, presented by Kenneth Anderson, MD
The Promise of Early Detection and Interception in Myeloma, presented by Irene Ghobrial, MDCAR T-cells in Multiple Myeloma,
presented by Adam Sperling, MD, PhDMultiple Myeloma: A Patient's Experience, presented by James and Kathleen BondThe Ongoing Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, presented by Clifton Mo, MDFuture Directions for Novel and Next Generation Therapy in Multiple Myeloma,
presented by Paul Richardson, MD
Updates in Managing Bone Disease in Multiple Myeloma, presented by Monique Hartley-Brown, MD, MMScMyeloma 101: Diagnosis, Prognosis, and Risk,
presented by Nikhil Munshi, MDBispecific Antibodies in Multiple Myeloma, presented by Omar Nadeem, MDSymptom Management in Multiple Myeloma,
presented by Shonali Midha, MDUpdates on AL Amyloidosis Treatment: What Is New in 2023, presented by Giada Bianchi, MD
New Patient Appointments
For adults: 877-442-3324For children: 888-733-4662
Learn more about Dana-Farber's Multiple Myeloma Program